Cargando…

Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study

BACKGROUND: Some studies have suggested that the suppression of endogenous LH secretion does not seem to affect the majority of patients who are undergoing assisted reproduction and stimulation with recombinant FSH (r-FSH). Other studies have indicated that a group of normogonadotrophic women down-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco, José G, Baruffi, Ricardo LR, Oliveira, João Batista A, Mauri, Ana L, Petersen, Claudia G, Contart, Paula, Felipe, Valeria
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701434/ https://www.ncbi.nlm.nih.gov/pubmed/19497101 http://dx.doi.org/10.1186/1477-7827-7-58

Ejemplares similares

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis
por: Oliveira, João Batista A, et al.
Publicado: (2010)

A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
por: Chen, Ming-Jer, et al.
Publicado: (2022)

Determination of Half-lives of Circulating FSH and LH Glycoforms in Women During GnRH Receptor Blockade
por: Wide, Leif, et al.
Publicado: (2022)

Corrigendum: A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
por: Chen, Ming-Jer, et al.
Publicado: (2022)

The Effect of Photoperiodic Conditions on GnRH/LH Secretion in Ewes
por: Kopycińska, Kamila, et al.
Publicado: (2022)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)

Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2015)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2013)

The value of LH maximum level in predicting optimal oocyte yield following GnRH agonist trigger
por: Lee, William Hao-Yu, et al.
Publicado: (2023)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

A propensity score matching comparison between GnRH agonist and GnRH antagonist protocols in patients in POSEIDON groups 3 and 4
por: Tan, Jifan, et al.
Publicado: (2023)

Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization
por: Jing, Miaomiao, et al.
Publicado: (2020)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

Using Aptamers as a Novel Method for Determining GnRH/LH Pulsatility
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2020)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
por: Yang, Wen-Jui, et al.
Publicado: (2009)

Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk
por: Gao, Rui, et al.
Publicado: (2022)

Use of GnRH Agonist in Dogs Affected with Leishmaniosis
por: Pugliese, Michela, et al.
Publicado: (2021)

Immunocontraceptive potential of a GnRH receptor-based fusion recombinant protein
por: Sandam, Nathaniel Philip, et al.
Publicado: (2021)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
por: Cho-Clark, Madelaine J., et al.
Publicado: (2023)

A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience
por: Kaur, Harpreet, et al.
Publicado: (2012)

Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders
por: Fàbregues, Francesc, et al.
Publicado: (2019)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
por: Lv, Mu, et al.
Publicado: (2022)

Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing
por: GIZZO, SALVATORE, et al.
Publicado: (2015)

Recombinant LH supplementation improves cumulative live birth rates in the GnRH antagonist protocol: a multicenter retrospective study using a propensity score-matching analysis
por: Wang, Meng, et al.
Publicado: (2022)

Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
por: Benmachiche, Abdelhamid, et al.
Publicado: (2017)

Melatonin Inhibits GnRH-1, GnRH-3 and GnRH Receptor Expression in the Brain of the European Sea Bass, Dicentrarchus labrax
por: Servili, Arianna, et al.
Publicado: (2013)

Self-Detection of the LH Surge in Urine After GnRH Agonist Trigger in IVF—How to Minimize Failure to Retrieve Oocytes
por: Cozzolino, Mauro, et al.
Publicado: (2020)

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
por: Turgay Çelik, Gayem İnayet, et al.
Publicado: (2015)

Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023)

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
por: Alyasin, Ashraf, et al.
Publicado: (2016)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

GnRH agonist-triggering ovulation in women with advanced age
por: Rahav Koren, Roni, et al.
Publicado: (2022)

GnRH agonists in the treatment of symptomatic endometriosis: a review
por: Surrey, Eric S.
Publicado: (2022)

Clinical development of the GnRH agonist leuprolide acetate depot
por: Chwalisz, Kristof
Publicado: (2022)

A mathematical model for LH release in response to continuous and pulsatile exposure of gonadotrophs to GnRH
por: Washington, Talitha M, et al.
Publicado: (2004)

A Two-Pathway Mathematical Model of the LH Response to GnRH that Predicts Self-Priming
por: Evans, J. J., et al.
Publicado: (2013)

Comparison of two different starting dose of rhFSH in GnRH antagonist protocol for patients with normal ovarian reserve
por: Jia, Zhi-cheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a9f4l6ibdf015vh8t1oetdt9mf